Page 131 - THE EVOLUTION OF EARLY ARTHRITIS AND CARDIOVASCULAR RISK Samina A. Turk

30. SodergrenA,KarpK,BomanK,ErikssonC,LundstromE,SmedbyT,etal.Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness. Arthritis Res Ther 2010;12:R158.
31. TonVK,MartinSS,BlumenthalRS,BlahaMJ.ComparingthenewEuropeancardiovascular disease prevention guideline with prior American Heart Association guidelines: an editorial review. Clin Cardiol 2013;36:E1-E6.
32. vanHalmVP,NielenMM,NurmohamedMT,vanSD,ReesinkHW,VoskuylAE,etal.Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis. Ann Rheum Dis 2007;66:184-8.
33. Panoulas VF, Douglas KM, Milionis HJ, Stavropoulos-Kalinglou A, Nightingale P, Kita MD, et al. Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology (Oxford) 2007;46:1477-82.
34. van Breukelen-van der Stoep DF, van ZD, Klop B, van de Geijn GJ, Janssen HJ, van der Meulen N, et al. Marked underdiagnosis and undertreatment of hypertension and hypercholesterolaemia in rheumatoid arthritis. Rheumatology (Oxford) 2016;55:1210-6.
35. van den Oever IAM, Heslinga M, Griep EN, Griep-Wentink HRM, Schotsman R, Cambach W, et al. Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the Implementation of Cardiovascular Risk Management in Rheumatoid Arthritis project. Rheumatology (Oxford) 2017.
36. Davis JM, III, Maradit KH, Crowson CS, Nicola PJ, Ballman KV, Therneau TM, et al. 6 Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based
cohort study. Arthritis Rheum 2007;56:820-30.
37. SolomonDH,AvornJ,KatzJN,WeinblattME,SetoguchiS,LevinR,etal.Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum 2006;54:3790-8.
38. SuissaS,BernatskyS,HudsonM.Antirheumaticdruguseandtheriskofacutemyocardial infarction. Arthritis Rheum 2006;55:531-6.
39. Kerola AM, Kauppi MJ, Kerola T, Nieminen TV. How early in the course of rheumatoid arthritis does the excess cardiovascular risk appear? Ann Rheum Dis 2012;71:1606-15.
40. Klarenbeek NB, van der Kooij SM, Huizinga TJ, Goekoop-Ruiterman YP, Hulsmans HM, van Krugten MV, et al. Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trial. Ann Rheum Dis 2010;69:1342-5.
41. URL:https://www.mdcalc.com/framingham-coronary-heart-disease-risk-score (accessed June 2017).
42. Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ 2017;357:j2099.
43. Arts EE, Popa CD, Den Broeder AA, Donders R, Sandoo A, Toms T, et al. Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms. Ann Rheum Dis 2016;75:674-80.
44. Crowson CS, Rollefstad S, Kitas GD, Van Riel PL, Gabriel SE, Semb AG. Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis. PLoS One 2017;12:e0174656.
CHANGE IN CARDIOVASCULAR RISK
129